Avalo Therapeutics Inc Cash Flow-to-Debt Ratio
Avalo Therapeutics Inc cash flow-to-debt ratio. Avalo Therapeutics Inc (AVTX) has a Cash Flow-to-Debt Ratio of -0.49x as of September 2025, meaning its operating cash flow of $-16.36 Million could theoretically repay 0% of its total liabilities ($33.55 Million) in one year. Check Avalo Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Avalo Therapeutics Inc (2012–2024)
Cash flow-to-debt ratio of Avalo Therapeutics Inc from 2012 to 2024. Historical debt coverage capacity for Avalo Therapeutics Inc across 13 annual periods. Check total reinvestment intensity of Avalo Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Avalo Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
Avalo Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Avalo Therapeutics Inc. For the full cash flow conversion analysis, see AVTX cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.77x | $-49.06 Million | $17.70 Million | ▼ -23.7% |
| 2023 | -2.24x | $-30.68 Million | $13.69 Million | ▼ -271.0% |
| 2022 | -0.60x | $-26.75 Million | $44.28 Million | ▲ +51.3% |
| 2021 | -1.24x | $-70.89 Million | $57.13 Million | ▲ +41.3% |
| 2020 | -2.11x | $-40.54 Million | $19.19 Million | ▼ -66.8% |
| 2019 | -1.27x | $-19.13 Million | $15.11 Million | ▼ -1897.1% |
| 2018 | -0.06x | $-3.13 Million | $49.34 Million | ▼ -107.7% |
| 2017 | 0.82x | $12.52 Million | $15.26 Million | ▲ +131.3% |
| 2016 | -2.62x | $-14.57 Million | $5.56 Million | ▼ -121.0% |
| 2015 | -1.19x | $-10.16 Million | $8.57 Million | ▼ -195.2% |
| 2014 | -0.40x | $-15.52 Million | $38.65 Million | ▲ +19.9% |
| 2013 | -0.50x | $-11.49 Million | $22.92 Million | ▲ +91.7% |
| 2012 | -6.02x | $-9.29 Million | $1.54 Million | — |